We are live on ! Find out more
RC

RegentAtlantic Capital Portfolio holdings

AUM $3.34B
1-Year Est. Return 14.54%
This Fund
S&P 500
This Quarter Est. Return
+19.34%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
AUM
$1.8B
AUM Growth
+$512M
Cap. Flow
+$280M
Cap. Flow %
15.57%
Top 10 Hldgs %
35.62%
Holding
492
New
76
Increased
227
Reduced
151
Closed
16

Sector Composition

Rank Sector Weight
1 Technology 16.6%
2 Healthcare 11.13%
3 Financials 9.43%
4 Communication Services 7.73%
5 Industrials 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHW icon
451
Sherwin-Williams
SHW
$82.7B
$204K 0.01%
+1,059
New +$191K
DELL icon
452
Dell
DELL
$262B
$203K 0.01%
+7,302
New +$164K
GSK icon
453
GSK
GSK
$104B
$203K 0.01%
+3,977
New +$204K
AWK icon
454
American Water Works
AWK
$26.7B
$202K 0.01%
+1,573
New +$196K
BCE icon
455
BCE
BCE
$20.2B
$202K 0.01%
+4,844
New +$199K
CBOE icon
456
Cboe Global Markets
CBOE
$32.5B
$200K 0.01%
+2,144
New +$211K
ESBA icon
457
Empire State Realty Series ES
ESBA
$1.34B
$200K 0.01%
27,338
TGNA
458
DELISTED
TEGNA Inc
TGNA
$195K 0.01%
17,514
-11,669
-40% -$130K
MRO
459
DELISTED
Marathon Oil Corporation
MRO
$178K 0.01%
+29,157
New +$161K
AMCR icon
460
Amcor
AMCR
$20.8B
$156K 0.01%
3,052
+740
+32% +$34.5K
EQNR icon
461
Equinor
EQNR
$97.7B
$149K 0.01%
10,296
-3,826
-27% -$53.8K
KYN icon
462
Kayne Anderson Energy Infrastructure Fund
KYN
$2.47B
$135K 0.01%
25,510
BMY.RT
463
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$108K 0.01%
30,076
+2,280
+8% +$8.23K
F icon
464
Ford
F
$58.5B
$98K 0.01%
16,127
+1,464
+10% +$8.11K
GMZ
465
DELISTED
Goldman Sachs MLP Income Opportunities Fund
GMZ
$96K 0.01%
+10,000
New +$101K
ET icon
466
Energy Transfer Partners
ET
$70.1B
$85K ﹤0.01%
11,975
-109
-0.9% -$808
SIRI icon
467
SiriusXM
SIRI
$9.97B
$85K ﹤0.01%
1,443
+105
+8% +$5.88K
TLRY icon
468
Tilray
TLRY
$618M
$78K ﹤0.01%
+1,092
New +$88.1K
LVO icon
469
LiveOne
LVO
$61M
$63K ﹤0.01%
+1,728
New +$48.3K
BKD icon
470
Brookdale Senior Living
BKD
$3.49B
$44K ﹤0.01%
15,000
CMMB
471
Chemomab Therapeutics
CMMB
$11.4M
$34K ﹤0.01%
+391
New +$26.5K
OPK icon
472
Opko Health
OPK
$985M
$34K ﹤0.01%
+10,000
New +$22.4K
YARW
473
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
$26K ﹤0.01%
+4
New +$27.1K
MTNB icon
474
Matinas BioPharma
MTNB
$1.88M
$15K ﹤0.01%
400
NMTR
475
DELISTED
9 Meters Biopharma
NMTR
$7K ﹤0.01%
+600
New +$6.76K

Similar funds

RegentAtlantic Capital's Q2 2020 Portfolio in Review

As of Q2 2020, RegentAtlantic Capital held 492 positions worth $1.8B, up 40% from $1.28B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

RegentAtlantic Capital deployed $280M of net new capital in Q2 2020, opening 76 new positions and adding to 227 existing holdings. Its largest new stake was Vanguard Morningstar Growth ETF: 4,397,400 shares worth $148M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Global ex-US Real Estate ETF, an estimated $10.5M trimmed.

  • RegentAtlantic Capital's largest Q2 2020 buy was Vanguard Morningstar Growth ETF: 4,397,400 shares worth $148M.
  • RegentAtlantic Capital added most to Vanguard Real Estate ETF in Q2 2020, an estimated $63.1M increase.
  • RegentAtlantic Capital's biggest Q2 2020 reduction was Vanguard Global ex-US Real Estate ETF, cutting an estimated $10.5M.
  • RegentAtlantic Capital fully exited Raytheon Company in Q2 2020, selling an estimated $5.69M.
  • RegentAtlantic Capital's ten largest holdings make up 36% of its $1.8B portfolio in Q2 2020.
  • RegentAtlantic Capital opened 76 new positions and closed 16 in Q2 2020.
  • RegentAtlantic Capital's portfolio value rose 40% quarter-over-quarter to $1.8B.

Based on RegentAtlantic Capital's 13F filing for Q2 2020, filed 13 Aug 2020.